Evolving Evidence-Based Treatment Guidelines for Iron Deficiency Anemia in Inflammatory Bowel Disease: Considerations in Managed Care
This activity will review the role of IV iron replacement in IBD and IDA and focus on the economic burden of these disease states and the impact of IV iron on healthcare resource use.
Hepatocellular Carcinoma: Perspectives on Disparities in Care and Managed Care Considerations in an Evolving Treatment Landscape
This discussion will highlight recently approved and emerging therapeutic options in the HCC treatment landscape and address resource utilization strategies for managed care professionals to consider when determining the most appropriate management plans for patients.
Assessing the Value of New Treatment Strategies in Inflammatory Bowel Disease: A Review of Clinical Data and Managed Care Implications
Identify various treatment strategies that managed care professionals can implement to help improve patient adherence, clinical outcomes, and decrease healthcare costs associated with IBD.
Prospects of S1P Inhibitors for Treatment of Ulcerative Colitis: What Pharmacists Need to Know
This activity will review the importance of managing patient expectations and investigate the potential place of S1P inhibitors in the UC treatment paradigm.